2025年9月30日 紫金矿业（601899.SH，02899.HK）旗下的 紫金黄金国际有限公司 （以下简称"紫金黄金国际"） 成功在港交所发行上市 股票代码：2259.HK 发行价格：71.59港元/股 开盘高开55.75％，报111.5港元/股 截至午间收盘 紫金黄金国际主要财务数据 紫金黄金国际的财务表现非常亮眼。2024年，公司营业收入达 29.90亿美元，净利润为6.21 亿美元，归母净利润为4.81亿美元。2025年上半年，公司业绩继 续保持高速增长，同比增长42.3%，至19.97亿美元；归母净利润同比增长142.6%，至5.20亿美元。2022-2024年，公司归母净利润的复合年增长率为61.9%。 | | | | 截至12月31日止年度 | | | | | 裁至6月30日止六個月 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 2022年 | | 2023年 | | 2024年 | | 2024年 | | 2025年 | | | | 美元 | 9/0 | 美元 | % | 美元 | ...

Core Insights - Ingram Micro Holding Corporation is preparing for a public offering again, but concerns exist regarding sales declines, thin margins, and increased debt levels [1] Group 1: Company Overview - Ingram Micro operates in a competitive and rapidly changing technology distribution sector [1] Group 2: Financial Performance - The company has experienced sales declines, which raises concerns about its financial health [1] - The margins are described as thin, indicating potential challenges in profitability [1] - Increased debt levels have been noted, which could impact the company's financial stability [1]

After 17 Years, Fintech Wealthfront Files For An IPO, Disclosing Fat Profitshttps://t.co/QILEvmhTDI https://t.co/TnDteBmrJ9 ...

(Bloomberg) — Wealthfront Corp., a robo-advisory firm, filed publicly for an IPO amid a slew of fintech companies pursuing long-awaited listings. The Palo Alto, California-based company had net income of $60.7 million on revenue of $175.6 million for the six months ended July 31, compared with net income of $132.3 million on revenue of $145.9 million a year earlier, according to a filing Monday with the US Securities and Exchange Commission. Most Read from Bloomberg Wealthfront had previously filed conf ...

A new report by EY has revealed that despite tariff uncertainty, the medtech industry has recorded its seventh successive year of top-line growth to reach a valuation of $584bn in the 12 months ended 30 June, with the sector on course to record 6% to 7% revenue growth by the end of 2025. EY’s Pulse of the MedTech Industry report found that medtech VC investments were up 16% in the first half of the year compared with the same period in 2024, with average financing rounds reaching $36m, reflecting a 122% i ...

He also leads the investing group IPO Edge , which offers actionable information on growth stocks through first-look IPO filings, previews on upcoming IPOs, an IPO calendar for tracking what’s on the horizon, a database of U.S. IPOs, and a guide to IPO investing to walk you through the entire IPO lifecycle - from filing to listing to quiet period and lockup expiration dates.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initi ...

Neptune is hoping its record of growth and profitability selling flood insurance policies will generate the same investor enthusiasm for its US IPO that greeted most debuts by other firms in the sector this year https://t.co/HPUsmU71vS ...

格隆汇新股 船娘摇橹摇出一个IPO，来自江苏扬州，今年上半年毛利率超63%！ 原创 阅读全文 ...

Tata Capital To Raise $1.7 Billion In What Could Be India’s Biggest IPO This Yearhttps://t.co/fdQMZPjFkf https://t.co/oswHqPm8sz ...

Core Viewpoint - Yifei Intelligent is preparing for an IPO in Hong Kong, with significant financial and operational details under scrutiny by regulatory authorities [1][2][4]. Group 1: Company Overview - Yifei Intelligent was established in 2012, focusing on the design, research and development, manufacturing, and commercialization of industrial robots, particularly in light industry applications [5]. - The company has completed 12 rounds of financing, raising a total of 634 million yuan, with a pre-IPO valuation of 3.604 billion yuan as of May this year [4][5]. Group 2: Financial Performance - The company anticipates a threefold increase in after-sales service fees by 2024, although its largest client's revenue has reportedly dropped by 80% [1]. - The funds raised from the IPO are intended for various purposes, including the development of robotic technology, production line development, expansion of overseas business networks, investments in the supply chain, and supplementing working capital [5]. Group 3: Regulatory Scrutiny - The China Securities Regulatory Commission has requested additional clarifications regarding equity changes, shareholder situations, and compliance with regulations concerning overseas listings [2][3]. - Specific inquiries include the rationale behind share pricing for new shareholders, the status of share pledges, and the operational status of the company's domestic subsidiaries [2][3].